Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.33 +0.06 (+0.73%)
At close: Sep 30, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) EV to CFO (2025 - 2026)

Updated

Biocryst Pharmaceuticals' EV to CFO was 5.85 in Q2 2026, down 93.9% from 96.37 a year earlier and down 16.0% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) EV to CFO (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Biocryst Pharmaceuticals' EV to CFO was 3.92 through Jun 30, 2026, down 90.2% year-over-year; for FY2025, it was 3.99.

  • Quarterly EV to CFO has moved between 3.99 (Q4 2025) and 96.37 (Q2 2025) over five years.
  • Per Business Quant data, BCRX's EV to CFO in the three quarters before Q2 2026 was 6.96 (Q1 2026), 3.99 (Q4 2025) and 27.59 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Biocryst Pharmaceuticals 2.11 Bn 1.03 Bn 214.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.85
Mar 31, 2026 6.96
Dec 31, 2025 3.99
Sep 30, 2025 27.59
Jun 30, 2025 96.37
API Access

Biocryst Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=BCRX&period=max&api_key=YOUR_API_KEY